READING, 01 August 2008 – Archimedes Pharma Ltd (“Archimedes”), the UK-based pan-European specialty pharmaceutical company, today announces that it has reached agreement with Molteni Farmaceuti to in-licence commercial rights in Germany for Oramorph®, an innovative liquid formulation of immediate release morphine sulphate which is approved for moderate to severe pain.
